CIK 0001472012 · Non-accelerated filer
Immunome Inc.
Sign in to watch- Ticker
- IMNM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770694340
- Phone
- 610-321-3700
- Business address
- 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL, WA, 98011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $334,224
- in 1 filing, $334K under 10b5-1 plans
Net −$334,224. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 56 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-11 | Higgins Jack Chief Scientific Officer | Option exercise 10b5-1 | +18,000 | $1.35 | $24K | 78,250 |
| 2026-09-11 | Higgins Jack Chief Scientific Officer | Sale 10b5-1 | −13,200 | $25.32 | $334K | 65,050 |
| 2026-09-11 | Higgins Jack Chief Scientific Officer | Gift 10b5-1 | −8,800 | 56,250 | ||
| 2026-09-11 | Higgins Jack Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) 10b5-1 | +18,000 | 133,840 | ||
| 2026-08-12 | Barchas Isaac Director | Sale 10b5-1 | −11,048 | $27.25 | $301K | 92,211 |
| 2026-08-11 | Barchas Isaac Director | Sale 10b5-1 | −62,291 | $26.23 | $1.6M | 0 |
| 2026-08-10 | Barchas Isaac Director | Sale 10b5-1 | −10,125 | $26.07 | $264K | 62,291 |
| 2026-08-07 | Barchas Isaac Director | Sale 10b5-1 | −15,248 | $26.06 | $397K | 72,416 |
| 2026-08-06 | Barchas Isaac Director | Sale 10b5-1 | −20,840 | $26.06 | $543K | 87,664 |
| 2026-08-04 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +50,366 | $12.92 | $651K | 50,366 |
| 2026-08-04 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise 10b5-1 | +40,250 | $10.60 | $427K | 90,616 |
| 2026-08-04 | Horn Kinney CHIEF BUSINESS OFFICER | Sale 10b5-1 | −90,616 | $25.09 | $2.3M | 0 |
| 2026-08-04 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −50,366 | 78,542 | ||
| 2026-08-04 | Horn Kinney CHIEF BUSINESS OFFICER | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −40,250 | 120,750 | ||
| 2026-07-23 | Tsai Philip Chief Technical Officer | Grant or award | +38,250 | 81,550 | ||
| 2026-07-23 | Tsai Philip Chief Technical Officer | Grant or award · Employee Stock Option (right to buy) | +76,500 | 76,500 | ||
| 2026-07-23 | Lechleider Robert Chief Medical Officer | Grant or award | +54,000 | 69,805 | ||
| 2026-07-23 | Lechleider Robert Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +108,000 | 108,000 | ||
| 2026-07-23 | Rosett Max Chief Financial Officer | Grant or award | +47,250 | 101,287 | ||
| 2026-07-23 | Rosett Max Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +94,500 | 94,500 |
Page 1 of 8 · 159 trades